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Summary 
The antigen receptors on T  and B lymphocytes can transduce both agonist and antagonist sig- 
nals leading either to activation/survival or anergy/death. The outcome of B lymphocyte anti- 
gen receptor (BCk) triggering depends upon multiple parameters which include (a) antigen 
concentration and valency, (b) duration of BCP,. occupancy, (c) receptor affinity, and (d) B cell 
differentiation stages.  Herein, using anti-immunoglobulin K and k  light chain antibodies, we 
analyzed the response of human naive, germinal center (GC) or memory B cells to BCR cross- 
linking regardless  of heavy chain Ig isotype or intrinsic BCR specificity. We show that after 
CD40-activation,  anti-BCR.(K+k)  can elicit an intracellular calcium flux on both  GC  and 
non-GC cells. However, prolonged BCP, cross-linking induces death of CD40-activated GC 
B cells but enhances proliferation of naive or memory cells. Anti-K antibody only kills K  + GC 
B cells without affecting surrounding k + GC B cells, thus demonstrating that BCR-mediated 
killing of GC B  lymphocytes is a direct effect that does not involve a paracrine mechanism. 
BCR-mediated killing of CD40-activated GC B cells could be partially antagonized by the ad- 
dition of IL-4. Moreover, in the presence of IL-4, prestimulation through CD40 could prevent 
subsequent anti-Ig-mediated cell death, suggesting a specific role of this combination in selec- 
tion of GC B cells. This report provides evidence that in human, susceptibility to BCP, killing 
is regulated along peripheral B cell differentiation pathway. 
I 
n the course of their ontogeny, lymphocytes enter win- 
dows of tolerance in which they are highly susceptible to 
inactivation  by  antigen-receptor  triggering  (1-3).  These 
windows are believed to represent fail-safe device for elim- 
inating  clones from the  peripheral repertoire that  exhibit 
autoreactivity. For example, when the preimmune  reper- 
toire is constituted, somatic translocation ofminigenes cod- 
ing for T  or B  cell antigen receptor variable regions may 
incidentally generate  autoreactive immature lymphocytes. 
However, the  newly formed repertoire is  rapidly purged 
from self-reactive clones as immature cells pass through a 
differentiation stage where self-epitope ligation induces an- 
ergy and/or deletion. 
After antigenic challenge, the introduction of somatic hy- 
permutations into the variable regions of mature lymphocyte 
antigen receptors brings further diversity to the preexisting 
repertoire. As somatic mutations are introduced randomly 
during cell division in germinal center (GC) l B cells (4, 5), 
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CD40-L, CD40 ligand; GC, germinal center. 
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it is conceivable that some of the hypermutated cells could 
exhibit reactivity to self-epitopes. Hence, a "second win- 
dow" (1) is required for elimination of auto-reactive clones 
before differentiation into memory or plasma cells. Studies 
in mice have provided evidence that, if arising in GC, au- 
toreactive mature B cell clones would be rapidly eliminated 
(6-8).  These experiments are based on the  principle that 
stimulation with large amounts of soluble antigen can mimic 
a situation where mature GC B cells are rendered autoreac- 
tive as a result of ongoing somatic mutations.  They show 
that antigen specific GC B cells die by apoptosis after solu- 
ble antigen administration. Simultaneously, B lymphocytes 
outside the follicle do not die but rather expand and differ- 
entiate into antibody secreting cells (9). Thus, censoring of 
autoreactive variants can specifically take place in GC. How- 
ever, it remains to be  elucidated  (a)  whether this antigen 
mediated effect could be due to direct B lymphocyte anti- 
gen receptor (BCIk) triggering ofGC B cells; (b) whether a 
higher a~nity for the antigen would be responsible for spe- 
cific killing of B cells, and (c) whether the agonist effect of 
soluble antigen outside the follicle results from stimulation 
of naive or memory cells. To address these issues, we puri- 
fied naive, GC and memory B cells from human tonsils ac- 
cording to the surface expression of IgD, IgG, IgA, CD38, 
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triggering  (that  may mimic  the  in  vivo  addition  of large 
amounts of soluble antigen) on CD40-activated naive, GC 
or memory B  cells were then analyzed. We show that pro- 
longed cross-linking ofCD44-  GC B  cell antigen receptor 
directly induces cell death. In contrast, the same BCK  trig- 
gering strongly enhances the proliferation of CD40-activated 
naive and memory cells. The relevance of this result is dis- 
cussed in the context of the GC reaction. 
Materials  and Methods 
Cytokines 
Purified rhlL-2 (3 ￿  106 U/ml; Amgen Biologicals, Thousand 
Oaks,  CA)  was  used  at  10  U/rnl,  rhlL-4  (107 U/mg),  rhlL-6 
(11 Ixg/ml), rhlL-10 (107 U/ml), (Schering-Plough Research In- 
stitute,  Kenilworth,  NJ)  were,  respectively, used  at  50  U/ml, 
5 ng/ml, and 100 ng/ml. IFN'y (107 U/mg) was purchased from 
Amgen and was used at 100 U/ml. Activated T  cell supernatant 
was prepared as follows: T cells were enriched by anti-CD14 and 
anti-CD19 depletion from total tonsillar cell suspension. The re- 
maining population  (>80%  CD3 +)  was  seeded  on  anti-CD3- 
coated plates in the presence of 1 txg/ml anti-CD28 mAb for 3 d. 
The supernatant included 8.8  -+ 0.3 ug/ml IFN-3' and 1.4 •  0.2 
ng/ml IL-10 as determined by specific ELISA (11) and were used 
at 1/4 final dilution. 
Antibodies 
The  monoclonal and polyclonal antibodies used  for pheno- 
typic and  functional studies were  obtained from  the  following 
sources:  Aster Laboratories (La  Gaude,  France),  anti-CD2  and 
anti-CD3 mAbs used for negative selection of  B cells with magnetic 
beads; Becton-Dickinson (Mountain View, CA), FITC-conjugated 
anti-CD2 (Leu 5), anti-CD3 (Leu 4), FITC-conjugated anti-CD20 
(Leu  16), anti-CD14 (Leu M3) antibodies; Dakopatts A/S (Glos- 
trup,  Denmark),  R-phycoerythrin-conjugated F(ab)'2 fragment 
of rabbit lg to human kappa or lambda light chain; Immunotech 
S.A.  (Marseille, France),  anti-K  (6E1),  anti-)t  (C4),  anti-CD28 
(CD28.2),  and FITC-conjugated anti-CD19  (IOB4)  antibodies; 
Kallestad Lab. Inc. (Austin,  TX), donkey polyclonal FITC-conju- 
gated antibody to total human Ig (Igtot); Sigma Chemical Company 
(St. Louis, MO),  FITC-conjugated anti-CD44 (A3D8) antibody 
and biotinylated goat anti-human IgD antibody. The anti-CD40 
(mAb 89) (12) and anti-CD40-L (CD40 ligand) (LL2) mAbs were 
generated and purified in the laboratory. Anti-CD38  (OKT10) 
antibody was purchased from American Type Culture Collection 
(ATCC,  Gaithersburg,  MD)  and  used  as  ascitic fluid. The  A2 
mAb was produced in the laboratory and determined as being an 
anti-CD44 mAb on the basis of reactivity pattern and competi- 
tion studies. It was used as 1:1,000  dilution ofascitic fluid. 
Chemicals 
FITC-conjugated streptavidin was purchased from Immunotech. 
Flow Cytometric Analysis 
Cell labeling.  Antibody binding was analyzed on a  FACScan  | 
flow cytometer (Becton-Dickinson). For viable B cell phenotype 
gating was set according to forward angle light scatter parameter 
and propidium iodide staining to exclude subcellular particles and 
dead  cells  from  acquisition data.  Data  were  subsequently pro- 
cessed using the LYSYS I program (Becton-Dickinson). 
Analysis of lntracellular Calcium Mobilization.  The method used 
has been described in detail elsewhere (13).  CD40 activated ton- 
sillar B  cells where loaded with  indo-1  by incubation with  its 
acetoxymethyl ester (Molectdar Probes, Junction City, OR) at 1 IxM 
concentration for 45 rain (37~  Cells were washed and kept at 
room temperature in the dark until analysis was performed with a 
FACStar  |  Plus (Becton-Dickinson). An argon laser was used for 
UV excitation. BCR stimulation was achieved by adding 20 Ixg/rnl 
of anti-K and anti-h mAbs cross-linked by an excess of goat anti- 
mouse antibody (Dako A/S). Violet fluorescent emission was de- 
tected at 405 nm and the blue emission was detected at 530 nm. 
The ratio oflndo-1 violet to blue fluorescence was displayed as a 
function of elapsed time.  The  entire analysis  was  performed at 
37~  with a typical flow rate of 600 cells/s. 
Cell Numeration.  The concentration of beads in a solution of 
fluorosphere for optical alignment of flow-cytometer (Immuno- 
chek, Coulter, FL) was determined (Cb). This solution was then 
used as an internal standard to calculate the number of viable B 
cell in samples. Briefly, a volume (Vc) of culture medium contain- 
ing an unknown  number of viable cells  (No) was  harvested.  A 
volume  (Vb) of beads  solution  was  added  before  propidium- 
iodide addition and FACS  |  analysis. The number  (No) of viable 
cells was then deternuned according to the formula: No=  (N1/ 
N2)'Cb'(Vb+Vc)  where  N l  and  N 2 represent,  respectively, the 
number of cells and beads recorded in an ungated 40,000  events 
acquisition data file.  The number of beads (N2) was  determined 
after acquisition by gating FL1 +  events.  The  number  of viable 
cells recorded (N1) was determined by gating propidium iodide 
negative cells. Nc was calculated as the average of five indepen- 
dent measurements. For Fig. 5, both Nc and the proportion of K 
or h  light chain among viable B cells were determined from the 
same culture well. 
B  Cell Purification 
Tonsillar mononuclear cells were separated by standard Ficoll/ 
Hypaque gradient method and were next submitted to E roset- 
ting with sheep red blood ceils. Non-rosetting cells were depleted 
by using antibodies against T  cells and monocytes, as previously 
described (14). The purity of the remaining B cell population was 
greater than 98%  as estimated by FACScan  |  analysis performed 
with anti-CD19, CD20, CD2, CD3, and CD14 monoclonal an- 
tibodies. Separation of resting vs GC B cells was done by further 
incubating cells with, respectively, (a) anti-CD38 (OKT10) or (b) 
anti-CD44 (A2) +  anti-lgD (Nordic lmmun., Tilburg, The Neth- 
erlands)  monoclonal antibodies before depletion with magnetic 
beads. The resting (CD44 +, CD38-) B  cell population could be 
further subdivided into naive or memory cells by depletion after 
staining with (a) anti-IgG +  anti-lgA or (b) anti-IgD antibodies, 
respectively. 
B  Cell Cultures 
All cultures were performed in RPMI  1640  medium supple- 
mented with 2  mM  L-glutamine (GIBCO  BILL,  Gaithersburg, 
MD), 10% heat-inactivated fetal calf serum (Flow Laboratories,  Irv- 
ine,  Scotland),  80  Ixg/ml  gentamicin  (Gentalline,  Schering- 
Plough,  Levallois  Perret,  France),  in  the  presence  of irradiated 
(7,000 rad) murine Ltk- cells trarksfected either with CD32 (CD32 
L-cells, ATCC;  16.2 CG7) or CD40-L (CD40-L L-cells), or with 
both  CD32  and CD40-L  (CD32/CD40-L  L-cells)  as previously 
described (15). Cultures were set up in flat-bottomed 96-well mi- 
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transfected  L cells/well.  Anti-CD40 or anti-BCR were used at 1 
ixg/ml.  For  [3H]thymidine  incorporation  assays, B  cells were 
seeded in flat-bottomed microtiter plates at a density ranging i~om 
5 ￿  104 (naive or memory) to 2 X  10  s (GC) B cells per well in a 
final volume of 100 p.1. Incorporation lasted  16h (1 p~Ci(37kBq)/ 
well)  and was measured by standard  liquid scintillation  counting 
techniques. 
Results 
Purification of Naive, GC or Memory B Cells.  Phenotypic or 
functional  characterization  of tonsillar  B  cells  subpopula- 
tions  has  been  reported  elsewhere  (16-19).  Here,  highly 
purified  tonsillar  B  cells  were  subdivided  into  resting  or 
GC cells. To this end, E- tonsillar B lymphocytes were in- 
cubated respectively with  antibodies  specific for either  (a) 
CD38  or  (b)  CD44  and  IgD. After magnetic bead deple- 
tion, the remaining cells were essentially composed of rest- 
ing (CD44 +, CD38-) or GC (CD44-, CD38 +) B cells, re- 
spectively.  Resting  cells  could be  further  subdivided  into 
naive  and  memory  cells  by depletion  using,  respectively, 
anti-IgG  +  anti-IgA or anti-IgD  antibodies.  The  average 
purity  of the  resulting  B  cell  subpopulations  assessed  by 
anti-CD38,  CD44 or IgD stainings was 85-90% for naive 
cells  and  >95%  for the  two  other  subsets  (Fig.  1).  Most 
contaminating  cells within  the naive B  cell subpopulation 
were found to be slgM+slgD -  lymphocytes (not shown). 
Consistent  with  previous  observations  (20--22),  GC  cells 
were different from any other tonsillar B  cells in that they 
expressed very low levels of surface Ig and CD44 antigen 
(Fig. 1). 
CD40 Stimulation Induces GC Cells to Express CD44 and 
BCR.  When differentiating into memory cells,  GC B cells 
reexpress  high levels of CD44 antigen  and surface immu- 
noglobulin. As CD40-1igand + T  cells were detected in the 
apical light zone of GC (23, 24), we asked whether in vitro 
CD40  stimulation  of CD44-  GC B  cells  would result  in 
upregulation  of BCIL  and  CD44  antigen.  To  this  end, 
freshly isolated CD44- GC B cells were seeded on CD40-L 
transfected fibroblasts. Then, CD44 or BCR expression on 
viable cultured cells was measured by FACS  |  analysis in a 
time  course  study from 6  to  120  h.  CD40  stimulation  of 
GC cells induced expression of the CD44 antigen (Fig. 2). 
This  induction  was  observed as soon  as  6  h  and  affected 
most viable B  cells after 72 h  (n =  4). CD40 triggering also 
induced BCK expression on GC cells (Fig. 2). This induc- 
tion was observed between 48 and 72 h  of culture  (n =  3) 
and  reached  optimal  level  after  96  h.  At this  time  point, 
most (87  +  12%, n =  3) viable cells expressed BCK. Thus, 
CD40  stimulation  of freshly isolated  GC  B  cells  induced 
the expression of both CD44 and BCK. 
BCR  Triggering of CD40 Activated GC Cells Antagonizes 
Their Proliferation and Affects Their Viability.  In view  that 
CD40 triggering reinduces BCK expression on GC B  cells, 
we asked what could be the outcome of BCR engagement 
on the proliferation of CD40-activated GC B lymphocytes. 
To address this issue,  GC as well as naive or memory cells 
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Figure  1.  Phenotype of naive, GC and memory tonsillar B cells. B cells were purified from human tonsils and stained with (a) anti-CD38 + anti-IgG 
+ anti-IgA (b) anti-CD44 + anti-IgD or (c) anti-CD38 + anti-lgD before depletion with goat anti-mouse coated beads. The resulting populations are 
CD19  + lymphocytes  expressing different levels of CD38, CD44 and lgD and are referred to as naive, GC or memory B cells. 
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Figure 2.  CD40 acnvation of GC cells induces expression of BCP, and CD44. CD44- B cells were purified from human tonsils and seeded on CD40- 
L-transfected fibroblasts. Cells were then stained with FITC-conjugated anti-CD44 mAb or with anti-~ +  anti-~, mAbs and R-phycoerythrin-conju- 
gated goat anti-mouse antibody. Vertical lines represents limit for non-specific binding as measured by unrelated isotype matched antibody stainings. 
were costimulated through  CD40 and BCR  by using anti- 
CD40  (mAb 89)  and anti-BCR  (K+k)  m.Abs cross-linked 
on  CD32  L-cells.  Proliferation  was  then  assessed by triti- 
ated  thymidine  incorporation  in a  time course study from 
day  1  to  day 6.  BCP,  stimulation  of CD40  activated  GC 
cells resulted  in a  reduced  proliferation  after a  5-d culture 
period (Fig. 3 B). This phenomenon was a dose-dependent 
process with a maximal effect obtained for i  b~g/ml ofanti- 
BCR.  At  this  concentration  point,  the  average thymidine 
incorporation was only 11.7  -+ 8.5%,  n  =  3 that of CD40- 
stimulated cells. This anti-proliferative effect of BC1L stim- 
ulation was observed from day 1 to day 6 and was associated 
with an inhibition  of GC B  cells culture  clumps formation 
(Fig.  4).  In contrast  to  GC B  cells,  addition  of anti-BCP,. 
mAbs to CD40-activated naive or memory B  lymphocytes 
resulted in a dose-dependent  enhancement  of proliferation 
with  a  maximal effect obtained  for  1 b~g/ml of anti-BCR 
(Fig.  3,  A  and  C).  Thus,  in  this  culture  system,  the  out- 
come of BClq. triggering depends on the stage of differenti- 
ation of the B  cell subset selected;  the proliferation of GC 
B  cells,  but  not  that  of naive  or  memory B  lymphocytes 
being inhibited  by BCR  triggering.  As illustrated  in Fig.  3 
E, BCR  cross-linking  actually affected viability of CD40- 
activated  GC B  cells.  Indeed,  after 5  d  of culture,  addition 
of 1 Izg/m/anti-BCR  to CD40-activated  GC B  lympho- 
cytes reduced by 60-70% the viability as measured by pro- 
pidium  iodide  exclusion.  In  contrast,  the  viability  of 
CD40-activated  naive  (Fig.  3  D)  or memory  (Fig.  3  F)  B 
cells was not significantly affected by anti-BCR  treatment. 
Comparable  results  could  be  obtained  by using  CD40-L/ 
CD32  double  transfected  L-cells  (not  shown).  Thus,  the 
inability to proliferate and survive in response to BCP, trig- 
gering is a functional feature of human GC cells. 
BCR  Stimulation  Affects  the  Viability  of CD40-Activated 
GC B Cells through a Direct Effect.  The BCR-mediated anti- 
proliferative effects may either be due  to  direct BCR  trig- 
gering or, as reported for T  cells, to the production of solu- 
ble or membranous factors with paracrine  antiproliferative 
potentials (25-28).  To address this issue, the numbers of vi- 
able k-(K +) and ~+(K-)  GC B  cells were quantified after a 
5-d culture  with CD40-L/CD32  transfected  L  cells in the 
presence or absence of anti-K mAb. Fig.  5 shows that both 
the proportion  (Fig.  5 A) and the absolute number (Fig.  5  B) 
of R-(K +) but not k+(K-) cells were decreased in the pres- 
ence  of anti-K  mAbs.  Similarly,  anti-k  triggering  reduced 
the viability of K-(k +)  GC B  ceils (not shown).  Taken to- 
gether, these results clearly show that the anti-BCR-induced 
cell death is a direct effect on triggered GC B  lymphocytes 
that does not involve a B  cell paracrine mechanism. 
Addition  of 11.-4 to  CD40-activated  GC  B  Cells  Partially 
Counteracts the Anti-proliferative  Effect of BCR  Cross-linking. 
We tested whether addition  of cytokines could reduce  the 
anti-proliferative  effect of BC1L triggering  on  GC B  lym- 
phocytes. GC B cells were cultured on CD40-L/CD32  dou- 
ble  transfected  L  cells  with  or  without  1  p~g/ml  of anti- 
BCt< (K+k) antibodies and in the presence of recombinant 
cytokines or activated T  cells supernatant.  The influence of 
cytokine  addition  on the  anti-proliferative  effects of BCP, 
stimulation  was  then  assessed  at  day  5  (Fig.  6).  Whereas 
IL-2,  IL-10,  IFN-',/,  or  IL-6 remained  mostly ineffective, 
addition  of IL-4  or  to  a  lesser  extent,  T  cell  supernatant 
could significantly counteract  the antiproliferative  effect of 
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BCB, cross-linking of CD40 activated GC cells antagonizes their proliferation and reduces their viability. Naive, GC or memory B  cells 
were activated on CD32-transfected L-cells in the presence of 1 I.~g/ml anti-CD40 mAbs and increasing concentrations of anti-BCR (K+ k) mAbs (upper 
panel). The proliferation was assessed on day 5 by [3H]thymidine incorporation assay. Black symbols show the profiferation in the presence of I  Ixg/ml of 
unrelated mAb. The viability or these cells was measured by flow cytometry using Propidium Iodide exclusion (lower panel).  Results are representative of 
three independent experiments￿9 
BCl~.-triggering  on  GC  cells.  Indeed,  in  the  presence  of 
IL-4, triggering of GC B  cells  only reduced  by 20%  the 
CD40-mediated thymidine uptake. However, none of the 
cytokines tested could drive GC cells to respond positively 
to BCR  stimulation.  As a  control,  addition  of anti-BCR. 
on CD40-activated resting cells  displayed an agonist effect 
on  the  proliferation  whatever  the  cytokines  used  (not 
shown).  Thus,  although IL-4 or T  cell supernatants could 
reduce  the  anti-prohferative effects of BCR.  triggering  on 
GC B  cells,  none of the cytokines tested nor T  cell super- 
natant could reverse this effect. 
CD40 +  IL-4 Preactivation  of GC B  Cells Prevents the An- 
tiproliferative Effect of BCR Triggering.  Because  optimal  ex- 
pression of BCR is observed on CD44- GC B cells after 3 d 
of stimulation through  CD40  (Fig.  2),  we asked whether 
death-promoting  effect of BCR.  triggering  could  also  be 
observed on GC B  lymphocytes after full reexpression of 
BCR.  GC  cells  were  preactivated  for  3  d  on  CD40-L- 
transfected L cells with or without IL-4. B  cells were then 
harvested, washed and reseeded on CD40-L/CD32 double 
transfected  L-cells,  in  the  presence  or  absence  of anti-Ig 
mAbs and IL-4. As shown in Fig. 7, whereas preactivation 
with  CD40-L  alone  did  not  prevent subsequent  anti-Ig- 
mediated cell death (Fig. 7 A), preincubation with CD40-L 
plus  IL-4 markedly inhibited  the  anti-Ig-mediated GC B 
cell death (Fig.  7 B).  Here again, the reduction in viability 
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of CD40-activated GC B  cells was associated with disrup- 
tion of cellular clumps (not shown).  Thus, CD40 stimula- 
tion of GC B  cells induced reexpression of BCR, the trig- 
gering of which displayed anti-proliferative effects. However, 
preactivation with  CD40-L and IL-4 protects GC B  cells 
from subsequent anti-Ig-mediated cell death. 
BCR Ligation  on CD40-activated Cells Elicits a Rise in Intra- 
cellular Free Calcium  Concentration.  Considering that anti- 
BC1L mediated growth inhibition can be associated or not 
with changes in cytosolic-free calcium concentration  (29), 
we asked whether intracellular Ca  2+ signals  would be ehc- 
ited by BCR.  stimulation  of CD40-activated  normal  GC 
cells. Thus, (CD44-IgD-) GC or (CD38-) resting tonsillar 
B  cells were purified and cultured for 4 d on CD40-L  § fi- 
broblasts. At this time point, both GC and resting cells ex- 
pressed  surface  immunoglobulins  as  measured by FACS  | 
labeang  (Fig.  8,  upper panel).  Cells  were  then  harvested, 
washed,  further cultured in fresh medium for 12 h  in the 
presence of anti-CD40-1igand antibody to avoid triggering 
by contaminating L cells,  and then loaded with Indo-1 dye 
before BC1L cross-linking and measurement of intracellular 
calcium  flux  by  flow  cytometry.  As  illustrated,  calcium 
fluxes of comparable duration were observed 15-20 s after 
BCR.  ligation  of both  CD40-activated  GC  or  resting  B 
cells.  However, the ampgtude of the calcium flux elicited 
on GC cells was slightly and reproducibly lower than that Figure 4.  Anti-BCR_ treatment precludes  to CD40-activated GC B cells clumps formation. CD44- GC (A and/3) or CD38- resting (C and D) B cells 
were cultured for 5 d on CD32-transfected fibroblasts in the presence of 1 txg/m/anti-CD40 mAb, with (B and D) or without (A and C) 1 ~g/ml anti- 
BCP,.(K+R) antibodies.  ￿  100. 
produced  on  resting B  cells  (n  =  3)  (Fig.  8).  Thus,  anti- 
BC1K cross-linking elicits a rise in intracellular Ca  2+ in both 
CD40-activated  GC  and  non-GC  cells.  As  previously  re- 
ported for malignant mature human  B  cells (30), differences 
further downstream in signal transduction pathway seem to 
be decisive for the outcome  death vs proliferation. 
Discussion 
Using anti-K and anti-k fight chain antibodies, we devel- 
oped a culture system where naive, GC and memory hu- 
man B cells perceive comparable BCR-stimulation regard- 
less of heavy chain Ig isotype or intrinsic BCR specificities. 
We show that a prolonged BCR cross-linking on CD40- 
activated  GC  cells  antagonizes their proliferation and  in- 
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Figure  5.  Anti-BCR.-medi- 
ated  cell  death is a  direct effect 
on triggered GC B lymphocytes. 
(.8) CD44-  GC  cells were  cul- 
tured for 5 d on CD40-L/CD32 
double transfected  L cells in the 
presence  (solid  line)  or  absence 
(dotted  line)  of  1  Ixg/ml  anti-K 
antibody  before  staining  with 
R-phycoerythrin  conjugated 
anti-h  antibody.  (/3)  Anti& 
staining was  coupled to cell nu- 
meration (as reported in Materi- 
als and Methods)  and the abso- 
lute number of R-  and h + was 
then detemlined. 
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but  not reversed by cytokines. CD44-  GC  B cells were cultured on 
CD40-L/CD32  double transfected L cells in the presence (bottom) or ab- 
sence (top) ofanti-BCR (K+h) mAbs with or without recombinant IL-2, 
IL-4, IL-6, IL-10, IFN"/ or activated T cell sup. On day 4, proliferation 
was assessed by [3H]thymidine  incorporation assay. 
duces cell death.  In contrast,  the same BCI< stimulation of 
CD40-activated  naive and memory B  cells  enhances  their 
proliferation.  These results  confirm previous in vivo find- 
ings  showing  that  GC  represents  a  window  for tolerance 
induction whereby auto-reactive B  cell clones, incidentally 
generated by somatic mutations,  could be  deleted  through 
prolonged  triggering by auto-antigens.  The  present  study 
further  characterizes  some features  of BCR-mediated  GC 
B  cell death:  (a) The cell-killing is a direct effect of BCP,- 
triggering as anti-K mAb only kills  K  +  GC B  cells without 
affecting the surrounding ~+  GC B  cells  (and vice-versa). 
Thus, antigen receptor mediated death of GC B  cells is dif- 
ferent from that of T  lymphocytes which relies on the pro- 
duction  of soluble/membrane-bound  factor  (FAS-ligand) 
with autocrine and paracrine  activity (25-28).  In addition, 
we failed to  detect  FAS-ligand mRNA  by PCR  in BCR. 
and CD40-stimulated  GC B  cells  (not shown).  These  re- 
suits are consistent with recent studies showing that GC B 
cells from lpr  (FAS deficient)  mice are fully susceptible  to 
soluble  antigen-induced  cell  death  (6).  (b)  In  this  report, 
the cell-killing effect of BCR-stimulation is observed with 
cross-linked anti-BCP, mAbs thus suggesting that membrane- 
bound or multivalent  auto-antigens  in  GC may also  elicit 
clonal  deletion  of self-reactive  clones.  However,  BCR- 
mediated GC cell death is not due to hypercross-linking of 
GC cell BCR  as previously reported for murine mature B 
cells  (31),  because  the  same  BCP,. stimulation  did not kill 
naive or memory B  cells.  (c) BCP,.-mediated killing of GC 
B  cells  could be  modulated but not reversed by the  addi- 
tion  of cytokines.  Consistent  with previous  reports  show- 
ing that CD40  +  IL-4 costimulation  reverse  BCR-medi- 
ated apoptosis of mature B  cells (31, 32), in the presence of 
IL-4, BCR  triggering only marginally affected viability or 
proliferation  of CD40-activated  GC  B  cells.  In  addition, 
CD40-L  +  IL-4 preincubation  protected  GC B  cells  from 
---O~  CD40-L 
A  ---0--  CD40-L+ anti-Ig (~:+K)  B 
2  32  g 
~  1 
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Time (Days) 
Figure 7.  Preactivation  with CD40-1igand and IL-4 prevents death promoting effect of  BCR triggering. CD44- GC B cells were cultured for 4 d on 
CD40-L/CD32  double transfected L cells in the presence (B) or absence (A) oflL-4. Cultured cells were then harvested and reseeded for 5 d on CD40- 
L/CD32 double transfected L cells in the presence ofAnti-BCR (K+M (black symbols) or unrelated mAb (white symbols). Number of  viable B cells was es- 
timated by propidium iodide exclusion as described in Materials and Methods. 
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Figure 8.  BCP,-triggering induces calcium flux on CD40-activated CD44- GC B cells. CD44- GC (A) and CD38- resting (B) B cells were purified 
from human tonsils and cultured for 4 d on CD40-L-transfected  fibroblasts. The calcium flux produced by cross-linked anti-BCP, (K+K) mAbs was then 
assessed by flow cytometry. (Top) BCP,. expression before (dotted  line) and after (solid line) CD40 stimulation as measured by FITC-conjugated donkey 
anti-human Ig. (Bottom) BCP, induced calcium flux by CD40-activated cells as measured by flow-cytometry using indo-1 dye. These results are repre- 
sentative of three independent experiments. 
subsequent anti-Ig-mediated cell death. This observation con- 
firms the hypothesis that CD40-L  +  IL-4 may play a par- 
ticular role in selection ofcentrocytes in GC (33). (d) BCR 
triggering  induced  comparable  calcium  fluxes  in  CD40- 
activated  GC  or  non-GC  cells,  thus  indicating  that  the 
proximal  events  of BCI< signal  transduction,  e.g.,  activa- 
tion of PLC-72,  are still  operative in CD40-activated  GC 
B lymphocytes (34) and that, as reported for follicular lym- 
phomas,  the  fate  of BCP,-triggered  cells  depends  upon 
other  components  of BCB.-associated  transduction  ma- 
chinery (30). 
Unlike  naive  or memory cells,  GC  cells  are  unable  to 
survive and proliferate in response to prolonged BCI< trig- 
gering.  The  molecular  basis  for  this  discrepancy  remains 
largely unknown:  a possibility could be that,  after in vivo 
antigenic  stimulation,  some  changes  occur  in  the  signal 
transduction apparatus associated with membrane immuno- 
globulin of cells  entering GC so that further in vitro or in 
vivo prolonged BCR stimulation would lead to cell death. 
Alternatively,  as proposed by Goodnow et al.  (3),  the fate 
of BClk-triggered  cells  could result from an interplay be- 
tween BCR.-mediated activation of cell death and concur- 
rent stimulation by survival factors eventually produced by 
stromal  elements.  The latter hypothesis is substantiated  by 
the finding that in vivo as well as in vitro acquisition  of a 
GC phenotype  abrogates autonomous production of IL-6 
by B lymphocytes without affecting B  cells IL-6 responsive- 
ness  (18,  35).  This result suggests that when entering win- 
dows  of selection,  B  cells  can  delegate  the  production  of 
trophic  factors  to  other  cellular  components  of their  mi- 
croenvironment  that  consequently  would  exert  a  control 
on B cell activation/survival. Although addition of IL-6 did 
not protect CD40-activated GC cells from anti-Ig-induced 
cell death, it is still possible that CD40-activated GC B cells 
are  killed  by in vitro  prolonged BCFL triggering  because 
they fail to produce survival factors which are normally pro- 
duced by CD40-activated  naive  or memory cells.  We  are 
presently investigating this point. 
In GC, stimulation through BCR  can lead either to de- 
letion of auto-reactive cells or to positive selection of high- 
affinity mutants  (4,  36, 37).  How can then GC B  lympho- 
cytes discriminate between foreign- and self-antigen? Such 
a discrimination  could be a  quantitative  issue.  As a matter 
of fact, the signal delivered by foreign-antigens trapped on 
2082  B Lymphocyte Antigen Receptor Triggering of Human Germinal Center Cells the surface of follicular dendritic cells might be shorter than 
that  delivered  by high  doses  of ubiquitous  auto-antigen. 
This  assumption  is  illustrated  by the  fact  that  short-term 
anti-BCR triggering may protect GC B cells from apopto- 
sis (38) whereas prolonged stimulation leads to death (7,  8, 
this report). Alternatively, there might be a context proper to 
foreign-antigen recognition by GC B cells. Foreign-antigen 
are retained in the form of antigen/antibody/C3 complexes 
on follicular  dendritic  cells  (39  for review).  GC B-lympho- 
cytes recognizing  the  foreign-antigen  may therefore  per- 
ceive cosignals from Fc (40)  or complement (C3) receptors 
(41-44) leading to the modulation of BCR stimulation and 
possibly influencing antigenic selection. Finally, GC B cells 
with a sufficient affinity for the foreign antigen may pick it 
up from FDCs and present it to antigen-specific T-lympho- 
cytes (45,  46). Unlike auto-reactive B lymphocytes, these B 
cells  could thereby perceive additional survival signals  that 
would allow positive selection to occur. 
When  differentiating  into  CD38-slgD-  memory cells, 
GC B  lymphocytes recover the abihty to proliferate in re- 
sponse to  BCl~-triggering.  Both  site  and  mechanisms by 
which  this  switch  occurs  remain unknown.  As  suggested 
above, it is possible that recovery of BCR proliferative po- 
tential corresponds to the reexpression of high levels of sur- 
vival genes.  However,  within  our hands,  CD40-stimula- 
tion  of CD44-  GC  B  cells  induces  high  levels  of Bcl-2 
expression (47 and not shown) but does not prevent BCP,,- 
mediated  cell  death,  In line  with  this  observation,  BCR 
stimulation of HF1,  a GC-like Bcl-2 + human B  cell lym- 
phoma, ehcits both intracellular calcium flux and apoptotic 
cell death (30,  48).  In addition, consistent with our results, 
overexpression of Bcl-2 in mice does not alter antigenic se- 
lection in GC (49). Unlike CD40 stimulation, costimulation 
with IL-4 and CD40 prevents subsequent anti-Ig-mediated 
cell death. This result is in line with previous report show- 
ing that apoptosis mediated by Ig hypercross-linking of pe- 
ripheral B  cells is reversed by CD40  +  IL-4 costimulation 
(31).  As suggested by others  (32),  production  of CD40-L 
(23,  24)  and  IL-4  (50)  by antigen-specific  T  cells  in  the 
light zone of GC could play a particular role in the preven- 
tion ofapoptosis and differentiation toward memory. 
As  a  conclusion,  the  present  report shows  that  a func- 
tional characteristic of human GC B cells lies in their inabil- 
ity to proliferate and survive in  response to prolonged in 
vitro BCR  triggering thus  further  illustrating  the  role  of 
GC in the induction of peripheral tolerance. As susceptibil- 
ity to BCR-mediated killing is regulated along B  cell dif- 
ferentiation pathway in secondary lymphoid organs, tonsil- 
lar B  cell subsets provide a unique  comparative model for 
studying the  molecular basis  of BCR  downstream events 
leading to either proliferation or cell death. 
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